|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,675.00 GBX | -0.89% |
|
+0.90% | +3.88% |
| Jan. 15 | EARNINGS AND TRADING: Titon profit swing; Brooks Macdonald funds rise | AN |
| Jan. 15 | Brooks Macdonald reports Q2 2026 total Fuma increased by 3% to £20.1 bln | RE |
| Capitalization | 259M 352M 297M 271M 480M 31.92B 499M 3.15B 1.25B 15.42B 1.32B 1.29B 53.88B | P/E ratio 2026 * |
18.4x | P/E ratio 2027 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise value | 223M 304M 256M 233M 413M 27.49B 430M 2.71B 1.08B 13.28B 1.14B 1.11B 46.4B | EV / Sales 2026 * |
1.84x | EV / Sales 2027 * | 1.68x |
| Free-Float |
88.25% | Yield 2026 * |
5.06% | Yield 2027 * | 5.31% |
Last Transcript: Brooks Macdonald Group plc
| 25-10-16 | AstraZeneca cut; Barclays raises Centrica | AN |
| 25-08-21 | RBC raises ConvaTec; Peel Hunt cuts Lancashire | AN |
| 25-05-09 | Morgan Stanley raises Haleon; Peel cuts Next | AN |
| 25-03-17 | RBC raises CVS Group to 'outperform' | AN |
| 24-11-29 | Berenberg starts M&S at 'hold', Next at 'buy' | AN |
| 1 day | -0.89% | ||
| 1 week | +0.90% | ||
| Current month | +4.69% | ||
| 1 month | +3.40% | ||
| 3 months | -3.18% | ||
| 6 months | -5.90% | ||
| Current year | +3.88% |
| 1 week | 1,620 | 1,700 | |
| 1 month | 1,600 | 1,700 | |
| Current year | 1,580 | 1,700 | |
| 1 year | 1,350 | 1,880 | |
| 3 years | 1,350 | 2,300 | |
| 5 years | 1,350 | 2,800 | |
| 10 years | 1,255.45 | 2,800 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrea Montague
CEO | Chief Executive Officer | - | 2024-09-30 |
Katherine Jones
DFI | Director of Finance/CFO | 45 | 2024-10-31 |
Eva Hatfield
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
John Linwood
BRD | Director/Board Member | 64 | 2018-09-18 |
Dagmar Kershaw
BRD | Director/Board Member | 58 | 2020-06-30 |
Robert Burgess
BRD | Director/Board Member | 61 | 2020-07-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.89% | +0.90% | +15.52% | -17.28% | 352M | ||
| +1.50% | +1.43% | +10.02% | +46.95% | 166B | ||
| -0.34% | -5.17% | +5.94% | +60.42% | 129B | ||
| +0.39% | +5.43% | +13.15% | +100.10% | 107B | ||
| +1.34% | +5.83% | -15.43% | +51.39% | 84.89B | ||
| +2.46% | -5.29% | +34.04% | +127.69% | 81.03B | ||
| +5.11% | +2.48% | -15.45% | +107.68% | 47.67B | ||
| +1.36% | -12.77% | -13.24% | +34.28% | 43.25B | ||
| +1.31% | -3.31% | +29.05% | +36.75% | 35.71B | ||
| +1.50% | -3.79% | +32.15% | +50.40% | 27.28B | ||
| Average | +1.37% | -1.27% | +9.57% | +59.84% | 72.28B | |
| Weighted average by Cap. | +1.31% | -0.55% | +8.17% | +69.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 121M 165M 139M 127M 224M 14.92B 233M 1.47B 584M 7.2B 618M 605M 25.18B | 126M 172M 145M 132M 234M 15.56B 243M 1.54B 610M 7.52B 644M 631M 26.27B |
| Net income | 16.45M 22.42M 18.89M 17.23M 30.54M 2.03B 31.73M 200M 79.56M 981M 84.08M 82.35M 3.43B | 19.78M 26.95M 22.71M 20.71M 36.71M 2.44B 38.14M 241M 95.64M 1.18B 101M 99M 4.12B |
| Net Debt | -35.92M -48.96M -41.26M -37.63M -66.69M -4.43B -69.29M -438M -174M -2.14B -184M -180M -7.48B | -47.42M -64.62M -54.45M -49.67M -88.02M -5.85B -91.45M -578M -229M -2.83B -242M -237M -9.88B |
Employees
473
Calendar
Feb. 24
- Q2 2026 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-02-13 | 1,675.00 p | -0.89% | 13,116 |
| 26-02-12 | 1,690.00 p | +0.30% | 20,378 |
| 26-02-11 | 1,685.00 p | -0.30% | 12,116 |
| 26-02-10 | 1,690.00 p | -0.59% | 18,085 |
| 26-02-09 | 1,700.00 p | +2.41% | 9,841 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
16.75GBP
Average target price
20.72GBP
Spread / Average Target
+23.71%
Annual profits - Rate of surprise
- Stock Market
- Equities
- BRK Stock
Select your edition
All financial news and data tailored to specific country editions

















